Aggressive antihypertensive therapy based on hydrochlorothiazide, candesartan or lisinopril as initial choice in hypertensive type II diabetic individuals: effects on albumin excretion, endothelial function and inflammation in a double-blind, randomized clinical trial

Publication | Open Access

DOI Full Paper Access

Citations

References

2005

Year

Miranda T. Schram, Frans J. van Ittersum, A. Man, Rob A.J.M. van Dijk, Casper G. Schalkwijk, Richard G. IJzerman, Jos W. R. Twisk, Coen D.A. Stehouwer

Journal of Human Hypertension

HypertensionDiabetes ManagementAlbumin ExcretionCardiovascular DiseaseAntihypertensive TherapyDiabetesPharmacologyCardiovascular PharmacologyPharmacotherapyMedicineAggressive Antihypertensive TherapyAtherosclerosisInitial Choice